Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Neuroscience professor to receive Freedman Prize for exceptional contribution to mental health research

David Foster, Ph.D., an assistant professor of neuroscience at the Johns Hopkins University School of Medicine, will be awarded the 2013 Freedman Prize Honorable Mention for Exceptional Basic Research at an awards ceremony in New York City on July 26.

25 Jul 2013

Study shows 90% of dementia cases in China go undetected; high level in rural areas

An international team of researchers has found that over 90 percent of dementia cases in China go undetected, with a high level of undiagnosed dementia in rural areas. The team of public health experts led by Dr Ruoling Chen at King's College London argues that more mental health education targeting high-risk populations is now needed to improve diagnosis rates, and increase support for sufferers and their families.

25 Jul 2013

Manchester scientists treat fatal genetic brain disease using stem cell gene therapy

Scientists from The University of Manchester have used stem cell gene therapy to treat a fatal genetic brain disease in mice for the first time.

From The University of Manchester 25 Jul 2013

Researchers identify key molecular pathways that lead to late-onset Alzheimer's disease

Key molecular pathways that ultimately lead to late-onset Alzheimer's disease, the most common form of the disorder, have been identified by researchers at Columbia University Medical Center (CUMC).

25 Jul 2013

Stopping cholesterol drugs may increase risk of Parkinson's disease

People who stop taking cholesterol drugs may be at an increased risk for developing Parkinson's disease, according to research that appears in the July 24, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

25 Jul 2013

Astrocytes can protect brain tissue and reduce disability due to stroke

One of regenerative medicine's greatest goals is to develop new treatments for stroke. So far, stem cell research for the disease has focused on developing therapeutic neurons - the primary movers of electrical impulses in the brain - to repair tissue damaged when oxygen to the brain is limited by a blood clot or break in a vessel. New UC Davis research, however, shows that other cells may be better suited for the task.

24 Jul 2013

NIH awards $1.7M grant to develop effective treatments for brain disorders

Ten percent of Americans experience a seizure in their lifetime, with three million diagnosed with epilepsy, a chronic neurological disorder. Anticonvulsant medications can mitigate the hyperactivity of neurons that leads to seizures, but not without severe side effects, including cognitive impairment.

23 Jul 2013

Results of post-mortem brain tissue study using Navidea's NAV4694 imaging agent presented at AAIC 2013

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.

23 Jul 2013

Chinese herbal medicine appears to be an effective treatment for vascular dementia

Chinese herbal medicine, which has been used for thousands of years in China, has long been considered an effective treatment for vascular dementia. There are already meta-analyses of the effects of herbal extracts (ginkgo biloba and huperzine A) on vascular dementia.

23 Jul 2013

Research roundup: Eye care disparities; more complications for Medicaid patients after spine surgery; the cost to states opting against Medicaid expansion

After analyzing 2003-2004 data of patients who underwent spinal surgery at two medical institutions, they found that Medicaid beneficiaries were at much higher risk of experiencing any type of complication than patients who are privately insured. "The results of our study further support the growing body of literature that Medicaid patients have higher rates of complications," the authors write. When evaluating patients and considering the likelihood of complications, "Medicaid status should be considered as well," they concluded (Hacquebord et al., 7/15).

20 Jul 2013

Family caregivers of older adults with dementia willing to stop cancer screening: Research

Research from the Regenstrief Institute and the Indiana University Center for Aging Research has found that many family caregivers of older adults with dementia are willing to consider stopping cancer screening of the elderly individual; they are also relieved when the older adult's physician brings it up.

20 Jul 2013

Viewpoints: Expanding abortion restrictions; Lift the ban on gay blood donors; Medicare's price schedules

What's going on in Wisconsin, North Dakota, South Dakota and Iowa ought to be a wake-up call to Minnesotans who prefer that physicians, not politicians, guide an individual's medical care. Minnesota's neighbors have moved with alarming alacrity to cripple women's access to a safe and legal medical procedure - abortion (7/18).

20 Jul 2013

Mayo Clinic, Banner Health work together on diagnostic test to identify early Parkinson's disease

Researchers from Mayo Clinic Arizona and Banner Sun Health Research Institute are working together on a diagnostic test to identify early Parkinson's disease in patients thanks to a $152,486 grant from The Michael J. Fox Foundation for Parkinson's Research.

19 Jul 2013

Computerized cognitive testing plays a key role in therapy development for dementia, AD

Computerized cognitive testing is increasingly playing a key role in therapy development for dementia and Alzheimer's disease. This week at the Alzheimer's Association International Conference, Keith Wesnes Ph.D., Practice Leader of Bracket and founder of the CDR System-, discussed new data for novel therapies at two poster presentations at the Alzheimer's Association International Conference.

19 Jul 2013

UK Markey Cancer Center receives National Cancer Institute designation

The University of Kentucky Markey Cancer Center was joined by national, state and local leaders last Friday to celebrate its designation as a National Cancer Institute cancer center.

19 Jul 2013

New data identifies specific cellular pathways by which RNS60 impacts Alzheimer's Disease

On Wednesday Revalesio Corporation presented new data at the Alzheimer's Association International Conference that identifies the specific cellular pathways by which Revalesio's lead investigational product, RNS60, impacts Alzheimer's Disease. This research, conducted in partnership with Rush University Medical Center, investigates a new category of therapeutics using Revalesio's novel nanotechnology platform.

19 Jul 2013

Early diagnosis of AD may prevent psychological and behavioral symptoms

Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the disease, indicates a recent study conducted at the University of Eastern Finland.

19 Jul 2013

Idera Pharmaceuticals receives patent related to IMO-8400

Idera Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has issued to Idera patent number 8,486,908, providing both composition of matter and method of use protection for IMO-8400.

19 Jul 2013

Transition Therapeutics' ELND005 receives Fast Track Designation from FDA

Transition Therapeutics Inc. announced that the US Food and Drug Administration has granted Fast Track Designation to the development program for ELND005 which was submitted for the treatment of Neuropsychiatric Symptoms in Alzheimer's disease.

18 Jul 2013

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

Scientists at the University of Massachusetts Medical School are the first to establish that a naturally occurring X chromosome "off switch" can be rerouted to neutralize the extra chromosome responsible for trisomy 21, also known as Down syndrome, a genetic disorder characterized by cognitive impairment.

18 Jul 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Neuroscience professor to receive Freedman Prize for exceptional contribution to mental health research

Study shows 90% of dementia cases in China go undetected; high level in rural areas

Manchester scientists treat fatal genetic brain disease using stem cell gene therapy

Researchers identify key molecular pathways that lead to late-onset Alzheimer's disease

Stopping cholesterol drugs may increase risk of Parkinson's disease

Astrocytes can protect brain tissue and reduce disability due to stroke

NIH awards $1.7M grant to develop effective treatments for brain disorders

Results of post-mortem brain tissue study using Navidea's NAV4694 imaging agent presented at AAIC 2013

Chinese herbal medicine appears to be an effective treatment for vascular dementia

Research roundup: Eye care disparities; more complications for Medicaid patients after spine surgery; the cost to states opting against Medicaid expansion

Family caregivers of older adults with dementia willing to stop cancer screening: Research

Viewpoints: Expanding abortion restrictions; Lift the ban on gay blood donors; Medicare's price schedules

Mayo Clinic, Banner Health work together on diagnostic test to identify early Parkinson's disease

Computerized cognitive testing plays a key role in therapy development for dementia, AD

UK Markey Cancer Center receives National Cancer Institute designation

New data identifies specific cellular pathways by which RNS60 impacts Alzheimer's Disease

Early diagnosis of AD may prevent psychological and behavioral symptoms

Idera Pharmaceuticals receives patent related to IMO-8400

Transition Therapeutics' ELND005 receives Fast Track Designation from FDA

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in